Brimonidine Tartrate Solution/ Drops
Product Images NDC 82182-321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 82182-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pacific Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Brimonidine Tartrate. (Brimonidine Tartrate Ophthalmic Solution 01)

FDA Label Image

Pacific Pharma Logo (Brimonidine Tartrate Ophthalmic Solution 02)

FDA Label Image

Pacificpharmandc 82182-773-05brimonidinetartrateophthalmicsolution, 0.15%5 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 03)

Pacificpharmandc  82182-773-05brimonidinetartrateophthalmicsolution, 0.15%5 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 03)
This text is a description of Brimonidine tartrate 0.15% solution used in ophthalmic treatments. It mentions the NDC code and suggests it should be used once in each eye per day. The text also lists the ingredients and the trademarks of the respective owners. The recommended storage temperature is between 15°C to 25°C.*
FDA Label Image

Pacificpharmandc 82182-773-10brimonidinetartrateophthalmicsolution, 0.15%10 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 04)

Pacificpharmandc  82182-773-10brimonidinetartrateophthalmicsolution, 0.15%10 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 04)
This is a product description of Brimonidine Tartrate ophthalmic solution 0.15%. It contains ingredients such as brimonidine tartrate, boric acid, calcium chloride, and potassium chloride. It also has a preservative called water URITE. The usual dosage requires using it three times a day or as directed by a physician. The product is patented, and the trademarks belong to their respective owners. It's distributed by Alergan, and the patent information can be found on their website. The storage instructions recommend storing it at 15-25 ºC.*
FDA Label Image

Pacificpharmandc 82182-773-15brimonidinetartrateophthalmicsolution, 0.15%15 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 05)

Pacificpharmandc  82182-773-15brimonidinetartrateophthalmicsolution, 0.15%15 mLsterilerx Only (Brimonidine Tartrate Ophthalmic Solution 05)
Brimonidine tartrate is an ophthalmic solution used to treat intraocular pressure in patients with glaucoma or ocular hypertension. The solution is 0.15%. The product is patented and manufactured in India. The solution contains various inactive ingredients such as boric acid, potassium chloride, and sodium chloride. The recommended dosage is one drop in the affected eye(s) every eight hours. The solution should be stored at 15-25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.